PKM and hepatocellular carcinoma: Furthermore, antisense oligonucleotides (cEt/DNA ASO) promote PKM splicing transition, facilitating PKM2-to-PKM1 conversion, thereby restoring PK activity, normalizing glucose metabolism, and inhibiting HCC cell proliferation (114).